{"currentpage":1,"firstResult":0,"maxresult":10,"pagecode":5,"pageindex":{"endPagecode":5,"startPagecode":1},"records":[{"abstractinfo":"以D,L-乳酸熔融聚合直接合成的低分子量聚外消旋乳酸(PDLLA)为原料,通过二异氰酸酯扩链合成聚乳酸类药物缓释材料,用2,4-甲苯二异氰酸酯(TDI)为扩链剂进行扩链的最佳工艺条件为:在SnCl2催化下,NCO/OH=1:1时,160℃下反应60min,分子量增加3.42倍,同时也提高了以乳酸为初始原料合成聚乳酸类药物缓释材料的利用率.","authors":[{"authorName":"王浚","id":"199a626b-754f-4bf1-a174-c4121da0a4b4","originalAuthorName":"王浚"},{"authorName":"汪朝阳","id":"cb171804-f5b2-4710-8ba3-6596063f9d5b","originalAuthorName":"汪朝阳"},{"authorName":"赵耀明","id":"3f143a0e-8b78-4a7a-a108-ac22e8210234","originalAuthorName":"赵耀明"}],"doi":"10.3969/j.issn.1671-5381.2003.01.002","fpage":"4","id":"00c19e12-ddad-4203-9b63-92429877a54e","issue":"1","journal":{"abbrevTitle":"HCCLLHYYY","coverImgSrc":"journal/img/cover/HCCLLHYYY.jpg","id":"42","issnPpub":"1671-5381","publisherId":"HCCLLHYYY","title":"合成材料老化与应用"},"keywords":[{"id":"4308e3d3-6ef7-48e1-9e55-d78e3c78ab5c","keyword":"2,4-甲苯二异氰酸酯","originalKeyword":"2,4-甲苯二异氰酸酯"},{"id":"5c96ca1d-0f14-42e0-966a-496d1321c61a","keyword":"扩链","originalKeyword":"扩链"},{"id":"e61a82ec-36af-4dac-8492-1db0f1577cae","keyword":"聚乳酸药物缓释材料","originalKeyword":"聚乳酸药物缓释材料"}],"language":"zh","publisherId":"hccllhyyy200301002","title":"二异氰酸酯扩链合成聚乳酸类药物缓释材料的研究","volume":"32","year":"2003"},{"abstractinfo":"以D,L-乳酸直接合成的低分子量聚外消旋乳酸(PDLLA)为原料,通过二异氰酸酯扩链合成聚乳酸类药物缓释材料,采用2,4-甲苯二异氰酸酯(TDI)为扩链剂,反应在四氢呋喃溶液中进行,扩链反应工艺条件为:在SnCl2催化下,NCO/OH摩尔比=1~2:1时,66°C下回流反应1~1.5h,分子量可增加3倍以上.与熔融扩链法相比,进一步提高了以乳酸为初始原料合成聚乳酸类药物缓释材料的利用率,且反应条件更为温和、易于调控.","authors":[{"authorName":"汪朝阳","id":"591e2654-514a-4bc1-9bc1-912fcfa278fd","originalAuthorName":"汪朝阳"},{"authorName":"王浚","id":"6f79e7c4-4b41-46c4-a2dd-d4c4fa2c626c","originalAuthorName":"王浚"},{"authorName":"赵耀明","id":"b2120f92-640e-4274-ab57-885e67960b0b","originalAuthorName":"赵耀明"},{"authorName":"王方","id":"4045e579-f0d5-4f61-a75d-e2696ebeacdb","originalAuthorName":"王方"},{"authorName":"游革新","id":"6b43bea6-c155-4042-881e-75da16a2860c","originalAuthorName":"游革新"}],"doi":"10.3969/j.issn.1671-5381.2004.01.001","fpage":"1","id":"da318d1b-1d1a-4d0f-b5e2-d07123c4494b","issue":"1","journal":{"abbrevTitle":"HCCLLHYYY","coverImgSrc":"journal/img/cover/HCCLLHYYY.jpg","id":"42","issnPpub":"1671-5381","publisherId":"HCCLLHYYY","title":"合成材料老化与应用"},"keywords":[{"id":"beba171c-3e6e-4283-95ff-b77d6457b99b","keyword":"2,4-甲苯二异氰酸酯","originalKeyword":"2,4-甲苯二异氰酸酯"},{"id":"37047932-196f-4a1e-8245-5f222012dccc","keyword":"溶液扩链","originalKeyword":"溶液扩链"},{"id":"21704523-b72b-4c5d-b8fb-49b270c708d8","keyword":"聚乳酸药物缓释材料","originalKeyword":"聚乳酸药物缓释材料"}],"language":"zh","publisherId":"hccllhyyy200401001","title":"二异氰酸酯扩链合成聚乳酸类药物缓释材料的研究Ⅱ.溶液法","volume":"33","year":"2004"},{"abstractinfo":"聚乳酸静电纺丝纳米纤维因具有孔隙率小、比表面积大等优点,在组织工程、药物控释等领域具有广阔的应用前景.文中综述了聚乳酸纳米纤维的制备方法及其结构形貌与性能,并介绍了聚乳酸纳米纤维作为药物缓释体系的载体对药物的负载和释放的研究现状,同时对聚乳酸纳米纤维在组织工程和生物医药等领域的研究进行了展望.","authors":[{"authorName":"李玉洁","id":"431b139f-514b-47bf-ba98-04e7e1dc51ae","originalAuthorName":"李玉洁"},{"authorName":"姚军燕","id":"2af707d8-826a-4920-b5d9-5a0cc721bdab","originalAuthorName":"姚军燕"},{"authorName":"陈明河","id":"7dcc0572-2e3b-4677-be67-5629e7bed963","originalAuthorName":"陈明河"},{"authorName":"苗旺","id":"5d734ada-f6a1-43cd-b66f-53ef68b4c4fe","originalAuthorName":"苗旺"}],"doi":"","fpage":"147","id":"bb736078-c75d-42f4-855d-1a15edaaef60","issue":"6","journal":{"abbrevTitle":"GFZCLKXYGC","coverImgSrc":"journal/img/cover/GFZCLKXYGC.jpg","id":"31","issnPpub":"1000-7555","publisherId":"GFZCLKXYGC","title":"高分子材料科学与工程"},"keywords":[{"id":"7bd917ed-c963-4f41-83c0-66e071001520","keyword":"聚乳酸","originalKeyword":"聚乳酸"},{"id":"de58ccda-9f69-4908-8a74-7baeedfccf36","keyword":"静电纺丝","originalKeyword":"静电纺丝"},{"id":"70e368e1-c23e-4e4a-becf-855e6871067d","keyword":"药物缓释","originalKeyword":"药物缓释"},{"id":"c884e817-28b8-4b0c-bdc5-1ab3140a483d","keyword":"纳米纤维","originalKeyword":"纳米纤维"}],"language":"zh","publisherId":"gfzclkxygc201406031","title":"聚乳酸静电纺丝纳米纤维及其药物缓释体系","volume":"30","year":"2014"},{"abstractinfo":"采用熔融聚合法直接合成生物降解材料聚乳酸-乙醇酸(PLGA),并以其为载体制备基因重组人干扰素聚乳酸-乙醇酸微球(IFN-α-PLGA-MS).通过正交试验对干扰素微球的制备工艺进行了优选,同时对微球的性质进行了考察.结果以D, L-乳酸、乙醇酸为原料,氯化亚锡(SnCl2)为催化剂,在165 ℃、70 Pa下熔融聚合10 h ,PLGA特性粘数[η]最高可达0.2382 dL/g,干扰素微球的形态圆整,平均粒径为10.71 μm,药物确已被包裹在微球中,微球载药量和包封率分别为8.06%、36.97%,且获得了较满意的干扰素微球制备工艺.","authors":[{"authorName":"杨帆","id":"7ed169db-8a85-4333-af49-8c042eb50696","originalAuthorName":"杨帆"},{"authorName":"汪朝阳","id":"ccf31bb3-cb1d-40c2-a318-0a8f140d147b","originalAuthorName":"汪朝阳"},{"authorName":"潘育方","id":"7a094a86-03a6-4b2c-b9f3-705df67095f4","originalAuthorName":"潘育方"},{"authorName":"洪慧","id":"d04c9490-bcdb-4609-a05e-10cf438e73c8","originalAuthorName":"洪慧"},{"authorName":"赵耀明","id":"e6eb44c5-75a3-4c0e-ac62-d9bd4710e781","originalAuthorName":"赵耀明"},{"authorName":"徐安龙","id":"dd97c87c-6ee6-4529-b526-166900b9fb76","originalAuthorName":"徐安龙"}],"doi":"","fpage":"77","id":"a39747a3-ff8b-4cf2-8055-1d354f98b3cb","issue":"3","journal":{"abbrevTitle":"GFZCLKXYGC","coverImgSrc":"journal/img/cover/GFZCLKXYGC.jpg","id":"31","issnPpub":"1000-7555","publisherId":"GFZCLKXYGC","title":"高分子材料科学与工程"},"keywords":[{"id":"9f2d280e-d284-40a5-a7d6-6f5ec8ff8237","keyword":"聚乳酸-乙醇酸","originalKeyword":"聚乳酸-乙醇酸"},{"id":"0921b26f-6413-42bb-9246-da5a3c749ed9","keyword":"直接熔融聚合","originalKeyword":"直接熔融聚合"},{"id":"6060b0c3-bd30-4966-bec8-666745550d03","keyword":"制备","originalKeyword":"制备"},{"id":"178214f4-a67c-4c70-968d-b40fac29a874","keyword":"干扰素-α","originalKeyword":"干扰素-α"},{"id":"e9d0bf04-3ee0-487c-8d3a-401336efdcb5","keyword":"微球","originalKeyword":"微球"}],"language":"zh","publisherId":"gfzclkxygc200503018","title":"聚乳酸-乙醇酸的合成及在药物缓释微球中的应用","volume":"21","year":"2005"},{"abstractinfo":"以L-聚乳酸为模型体系,超临界CO2为抗溶剂,采用超临界流体抗溶剂法制备聚乳酸微球.考察了压力、温度、溶液浓度、溶液流速、二氯甲烷-丙酮混合溶剂、聚合物分子量等参数对制备微球的形态、粒径及其分布的影响.结果表明,改变工艺参数,可在一定范围内调控微球粒径,所制微球平均粒径0.67~6.64μm,溶液浓度及其流速为主要影响因素;实验条件一定时,采用二氯甲烷-丙酮混合溶剂及强制分散溶液法制备得较小粒径微球.释放度实验结果表明,微球按一级释放方程释药,具缓释效果.","authors":[{"authorName":"蒲曦鸣","id":"34d6b359-a0c5-4126-ab32-deb821269404","originalAuthorName":"蒲曦鸣"},{"authorName":"康云清","id":"c01edcff-1794-4d2f-ae2e-c164d424004b","originalAuthorName":"康云清"},{"authorName":"陈爱政","id":"6d6b529b-eff6-479a-8554-30d28c67cc6e","originalAuthorName":"陈爱政"},{"authorName":"尹光福","id":"ad5c8ff4-e13d-473b-aa97-2d88f0f47832","originalAuthorName":"尹光福"},{"authorName":"廖立","id":"d9321160-153f-4f6e-85ff-5b065b006d58","originalAuthorName":"廖立"},{"authorName":"陈琳","id":"ff77f43a-c972-4466-ab21-dd4ec6eb3bf5","originalAuthorName":"陈琳"}],"doi":"","fpage":"549","id":"8a412659-a830-403b-a849-ec88b2d24c7a","issue":"4","journal":{"abbrevTitle":"GNCL","coverImgSrc":"journal/img/cover/GNCL.jpg","id":"33","issnPpub":"1001-9731","publisherId":"GNCL","title":"功能材料"},"keywords":[{"id":"fa95b9f1-d659-46c6-a6c1-05ff06c1bf16","keyword":"超临界二氧化碳","originalKeyword":"超临界二氧化碳"},{"id":"eb037d66-1905-4a2f-b669-126a886f7bd9","keyword":"抗溶剂法","originalKeyword":"抗溶剂法"},{"id":"167530a5-1814-428e-84a4-0e639b7833ff","keyword":"聚乳酸","originalKeyword":"聚乳酸"},{"id":"b505b051-68e7-4305-9758-2a5e1410a98b","keyword":"微球","originalKeyword":"微球"}],"language":"zh","publisherId":"gncl200704011","title":"超临界CO2抗溶剂法制备聚乳酸药物缓释微球","volume":"38","year":"2007"},{"abstractinfo":"综述了用聚乳酸类可生物降解型高分子材料制备缓控释药物载体的研究现状.分别介绍了该类材料在微粒给药载体、凝胶制剂、缓释支架和埋植制剂的应用及其制备方法.阐述了目前聚乳酸类生物降解材料在缓控释药物制剂中的主要问题,展望了其发展前景.","authors":[{"authorName":"梁兆丰","id":"47aa04f3-1edc-4a9c-bb61-b97185bc89da","originalAuthorName":"梁兆丰"},{"authorName":"温玉琴","id":"d5ff127b-3f4f-46cf-b926-4d2d8fcb25ff","originalAuthorName":"温玉琴"},{"authorName":"孙美丽","id":"997f77e6-d322-4e29-b6a6-a16dfcdcc577","originalAuthorName":"孙美丽"},{"authorName":"吕竹芬","id":"4ec8b968-16f0-4188-b815-c3b1435da9d2","originalAuthorName":"吕竹芬"}],"doi":"","fpage":"70","id":"83f1ab58-3cca-4bad-9775-371811ff8cd8","issue":"19","journal":{"abbrevTitle":"CLDB","coverImgSrc":"journal/img/cover/CLDB.jpg","id":"8","issnPpub":"1005-023X","publisherId":"CLDB","title":"材料导报"},"keywords":[{"id":"9f943515-d75c-4ffb-9ee1-3f77f994b20d","keyword":"聚乳酸","originalKeyword":"聚乳酸"},{"id":"3c337ef2-b1e0-450f-a704-73ea61014ecc","keyword":"缓控释制剂","originalKeyword":"缓控释制剂"},{"id":"7976da5c-de45-4172-9e1b-c24795337eda","keyword":"药物载体","originalKeyword":"药物载体"},{"id":"07fb56e1-91dc-48b2-9243-59960dec44c4","keyword":"生物可降解材料","originalKeyword":"生物可降解材料"}],"language":"zh","publisherId":"cldb201319015","title":"聚乳酸类可生物降解材料在缓控释药物制剂中的应用","volume":"27","year":"2013"},{"abstractinfo":"以DL-乳酸为原料,通过熔融聚合法直接合成外消旋聚乳酸(PDLLA).以SnCl2为催化剂,用量0.5%(质量),在170 ℃、70 Pa下反应10 h,获得了粘均分子量为4100的PDLLA,将其应用于红霉素肺靶向微球的载体.用正交试验确定了红霉素-聚乳酸微球(ERY-PDLLA-MS)最佳成型工艺条件,用DSC和SEM表征其成球性能.微球体外缓释半衰期为28 h,175 h后累积释药百分率约为80%.注射微球混悬剂的兔肺组织中药物含量为普通市售红霉素注射剂的6倍,达到了肺靶向的目的.","authors":[{"authorName":"赵耀明","id":"9405ced0-7a83-431e-8520-ae0eaf42eab4","originalAuthorName":"赵耀明"},{"authorName":"汪朝阳","id":"81613ceb-a97e-4f63-aeb2-780a8ee56a4f","originalAuthorName":"汪朝阳"},{"authorName":"麦杭珍","id":"f0118732-6acb-4db2-8f76-ce2e3af223f0","originalAuthorName":"麦杭珍"},{"authorName":"严冰","id":"af978ad9-9b33-484b-b8ef-c03cd9968735","originalAuthorName":"严冰"},{"authorName":"杨帆","id":"573ccef6-76f8-47b3-baa3-444c70edb07c","originalAuthorName":"杨帆"}],"doi":"","fpage":"145","id":"438d36da-b71f-40a8-bd46-8fecff62b43f","issue":"5","journal":{"abbrevTitle":"GFZCLKXYGC","coverImgSrc":"journal/img/cover/GFZCLKXYGC.jpg","id":"31","issnPpub":"1000-7555","publisherId":"GFZCLKXYGC","title":"高分子材料科学与工程"},"keywords":[{"id":"cc15b839-2f0c-42c2-bd4b-31b65cb20563","keyword":"DL-乳酸","originalKeyword":"DL-乳酸"},{"id":"da4db55c-dd86-4fe9-8d0f-fe9caa27e505","keyword":"聚乳酸","originalKeyword":"聚乳酸"},{"id":"ef25ee44-4a32-46c2-b647-3e0f7df402ac","keyword":"熔融聚合","originalKeyword":"熔融聚合"},{"id":"bf2dfb30-3090-4847-8ba8-e1a0f831d301","keyword":"微球","originalKeyword":"微球"},{"id":"c612ed3b-1c19-4466-af33-41491d8bcf30","keyword":"红霉素","originalKeyword":"红霉素"},{"id":"2e7aaeae-9c7f-4111-a60e-88a202b2a46b","keyword":"肺靶向","originalKeyword":"肺靶向"}],"language":"zh","publisherId":"gfzclkxygc200305038","title":"聚乳酸的直接合成及其红霉素肺靶向药物微球的应用","volume":"19","year":"2003"},{"abstractinfo":"研究试图通过本体改性,将生物素接枝到聚乙二醇接枝聚乳酸(PPLA)上,以改善聚乳酸微球在药物缓释应用中血液循环时间短和无主动靶向性的缺点.在本实验室制备的聚乙二醇接枝改性聚乳酸的基础之上,采用N-羟基琥珀酰亚胺活化酯法,将生物素接枝到PPLA上,制备生物素改性聚乳酸(BPLA),通过茚三酮显色、核磁共振(1H-NMR),差示扫描量热(DSC),静态水接触角、荧光蛋白标记法对材料进行表征与检测.结果表明,生物素已经共价接枝到聚乳酸上;与PPLA相比,BPLA明显降低了对牛血清白蛋白(BSA)的吸附,有望提高聚乳酸微球在血液循环系统中的停留时间;同时能与生物素的配体亲和素结合,有望通过生物素和亲和素的高亲和性实现主动靶向,可能使BPLA在药物缓释中有潜在应用价值.","authors":[{"authorName":"严好","id":"9540f8e7-f659-4762-a210-70e64116605c","originalAuthorName":"严好"},{"authorName":"潘君","id":"79e6699e-2741-424e-b065-eff7408e2a1a","originalAuthorName":"潘君"},{"authorName":"江伟民","id":"773f94ed-7c04-48a2-aab0-7424207b5c8a","originalAuthorName":"江伟民"},{"authorName":"张晓喜","id":"fb371fc5-d9b8-4848-af0d-0702c44ae54b","originalAuthorName":"张晓喜"},{"authorName":"王远亮","id":"ddd78c51-4944-4ce4-a212-eae80d6f496f","originalAuthorName":"王远亮"}],"doi":"","fpage":"399","id":"188cca7e-7dd6-402d-a1ed-ffcb965b17cd","issue":"3","journal":{"abbrevTitle":"GNCL","coverImgSrc":"journal/img/cover/GNCL.jpg","id":"33","issnPpub":"1001-9731","publisherId":"GNCL","title":"功能材料"},"keywords":[{"id":"6a54cd59-4dc1-4d76-9efa-3c0f829570ab","keyword":"聚乳酸","originalKeyword":"聚乳酸"},{"id":"a6847d32-c82f-4bf4-9dcd-033624e65b68","keyword":"生物素","originalKeyword":"生物素"},{"id":"374ee9d0-13fd-4e6c-9484-7d0cbc544c9b","keyword":"亲和素","originalKeyword":"亲和素"},{"id":"2bb994c6-3f01-4ede-9a95-153583552339","keyword":"生物活性","originalKeyword":"生物活性"},{"id":"5d0987a7-d47f-459d-b17a-15557687026e","keyword":"药物缓释","originalKeyword":"药物缓释"}],"language":"zh","publisherId":"gncl201103005","title":"一种生物素改性聚乳酸生物材料的制备与性能研究","volume":"42","year":"2011"},{"abstractinfo":"聚乳酸具有良好的生物降解性、生物相容性和生物可吸收性,研究其在水中的降解行为对于指导聚乳酸的改性,满足不同的实际需要有非常重要的意义.本文对聚乳酸类降解材料的水解机理、影响水解的因素进行了综述.","authors":[{"authorName":"刘磊","id":"5146b18b-a5ad-4753-8b59-8b177d4c092a","originalAuthorName":"刘磊"},{"authorName":"吴若峰","id":"16484495-e6c3-4a60-ac7c-46c40d607f2f","originalAuthorName":"吴若峰"}],"doi":"10.3969/j.issn.1671-5381.2006.01.012","fpage":"44","id":"ad00ec29-c421-4488-bfea-aba17ae212db","issue":"1","journal":{"abbrevTitle":"HCCLLHYYY","coverImgSrc":"journal/img/cover/HCCLLHYYY.jpg","id":"42","issnPpub":"1671-5381","publisherId":"HCCLLHYYY","title":"合成材料老化与应用"},"keywords":[{"id":"95f9f090-5770-440a-bfc1-a7526a63a13c","keyword":"聚乳酸","originalKeyword":"聚乳酸"},{"id":"0f5eddfa-f7ec-4903-a452-98333c320942","keyword":"水解","originalKeyword":"水解"},{"id":"43b3fd2c-4bae-4cec-a8e5-851b45715823","keyword":"机理","originalKeyword":"机理"}],"language":"zh","publisherId":"hccllhyyy200601012","title":"聚乳酸材料的水解特性","volume":"35","year":"2006"},{"abstractinfo":"采用向孔隙中灌注含聚乳酸-聚乙醇酸共聚物(PLGA)载药微球的明胶溶液的方法制备了具有药物缓释功能的明胶/磷酸钙骨水泥复合组织工程支架.用扫描电子显微镜观察了微球和支架的形貌特征,用万能材料试验机测定了支架材料的抗压强度,用紫外-可见分光光度计分析了复合支架的释药率.结果表明,灌注明胶对多孔磷酸钙骨水泥支架起到显著的增强作用,抗压强度达2.42MPa.复合支架携载硫酸庆大霉素,具有良好的药物缓释功能,缓释时间可达30天以上,使支架在修复骨缺损的同时能消除炎症反应,成为一种集骨修复和治疗于一体的新型组织工程支架材料,具有良好的应用前景.","authors":[{"authorName":"谭红香","id":"217bec58-6e77-4a01-afd2-002d18215e15","originalAuthorName":"谭红香"},{"authorName":"叶建东","id":"14755620-74d3-4d56-ba2d-b873f80753a2","originalAuthorName":"叶建东"},{"authorName":"董浩","id":"5db95ed3-e031-4dc1-b661-4f96ec98a036","originalAuthorName":"董浩"}],"doi":"","fpage":"77","id":"d93f770e-4b1c-41d4-9ac4-0737025055e7","issue":"6","journal":{"abbrevTitle":"FHCLXB","coverImgSrc":"journal/img/cover/FHCLXB.jpg","id":"26","issnPpub":"1000-3851","publisherId":"FHCLXB","title":"复合材料学报"},"keywords":[{"id":"f125ba7c-2279-4fbc-ad83-6a4f126e6d64","keyword":"磷酸钙骨水泥","originalKeyword":"磷酸钙骨水泥"},{"id":"1f2ec12e-7719-404f-b730-b7fdbed60ce5","keyword":"支架","originalKeyword":"支架"},{"id":"6616a23d-15ae-4522-a3e3-bb3d6b38629d","keyword":"PLGA微球","originalKeyword":"PLGA微球"},{"id":"bb105c61-e241-43b0-bbdf-b0a7f8127c96","keyword":"硫酸庆大霉素","originalKeyword":"硫酸庆大霉素"},{"id":"255f7842-86fc-4bdd-a610-fd5440c265a7","keyword":"明胶","originalKeyword":"明胶"}],"language":"zh","publisherId":"fhclxb200806015","title":"可缓释药物的明胶/磷酸钙骨水泥复合组织工程支架材料","volume":"25","year":"2008"}],"totalpage":5653,"totalrecord":56528}